Access
To read this story in full you will need to login or make a payment (see right).
Technical Report
Nature Medicine 10, 1257 - 1260 (2004)
Published online: 24 October 2004 | doi:10.1038/nm1120
Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model
Lene Uhrbom1,2,3, Edward Nerio2,3 & Eric C Holland2
Abstract
Bioluminescence imaging has previously been used to monitor the formation of grafted tumors in vivo and measure cell number during tumor progression and response to therapy. The development and optimization of successful cancer therapy strategies may well require detailed and specific assessment of biological processes in response to mechanistic intervention. Here, we use bioluminescence imaging to monitor the cell cycle in a genetically engineered, histologically accurate model of glioma in vivo. In these platelet-derived growth factor (PDGF)-driven oligodendrogliomas, G1 cell-cycle arrest is generated by blockade of either the PDGF receptor or mTOR using small-molecule inhibitors.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Loss of Arf causes tumor progression of PDGFB-induced oligodendrogliomaOncogene Original Article
Oligodendrocyte progenitor cells can act as cell of origin for experimental gliomaOncogene Original Article
Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescenceOncogene Original Article
Akt phosphorylation of La regulates specific mRNA translation in glial progenitorsOncogene Original Article
See all 5 matches for Research